Skip to Content
MilliporeSigma
  • Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain.

Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain.

Bioorganic & medicinal chemistry letters (2006-09-12)
Barrie Wilkinson, Matthew A Gregory, Steven J Moss, Isabelle Carletti, Rose M Sheridan, Andrew Kaja, Michael Ward, Carlos Olano, Carmen Mendez, José A Salas, Peter F Leadlay, Rob vanGinckel, Ming-Qiang Zhang
ABSTRACT

A set of novel borrelidin analogues have been prepared by precursor-directed biosynthesis. Structure-activity relationship analysis suggests that steric structural arrangement within the C17 side chain is important for differentiating cytotoxic and anti-angiogenic activities. A C17-cyclobutyl analogue 3 was found to have markedly increased selectivity for in vitro angiogenesis inhibition over cytotoxicity and is therefore potentially useful as an anticancer agent.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Borrelidin, from Streptomyces parvulus, ≥98% (HPLC)